Spider venom heart drug a step closer
A spider venom molecule being investigated by a University of Queensland team has met critical benchmarks towards becoming a treatment for heart attack and stroke. Associate Professor Nathan Palpant and Professor Glenn King from UQ’s Institute for Molecular Bioscience have previously shown that the drug candidate Hi1a protectscells from the damage caused by heart attack … Read more
